|
Volumn 13, Issue , 2012, Pages
|
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTACOID;
BIOLOGICAL MARKER;
ERGOCALCIFEROL;
PARICALCITOL;
ADULT;
AGED;
ARTICLE;
BLOOD;
CHRONIC KIDNEY FAILURE;
DRUG EFFECT;
FEMALE;
HUMAN;
INFLAMMATION;
MALE;
MIDDLE AGED;
OXIDATIVE STRESS;
PATHOLOGY;
PHYSIOLOGY;
RENAL REPLACEMENT THERAPY;
ADULT;
AGED;
BIOLOGICAL MARKERS;
ERGOCALCIFEROLS;
FEMALE;
HUMANS;
INFLAMMATION;
INFLAMMATION MEDIATORS;
MALE;
MIDDLE AGED;
OXIDATIVE STRESS;
RENAL DIALYSIS;
RENAL INSUFFICIENCY, CHRONIC;
MLCS;
MLOWN;
|
EID: 84883179647
PISSN: None
EISSN: 14712369
Source Type: Journal
DOI: 10.1186/1471-2369-13-159 Document Type: Article |
Times cited : (64)
|
References (0)
|